Format

Send to

Choose Destination
Hematol Oncol Clin North Am. 2009 Dec;23(6):1251-60. doi: 10.1016/j.hoc.2009.08.003.

Thyroid disease in patients with immune thrombocytopenia.

Author information

1
University of Southern California-Keck School of Medicine, Jane Anne Nohl Division of Hematology, Norris Comprehensive Cancer Center, Room 3466, 1441 Eastlake Avenue, Los Angeles, CA 90033-0800, USA.

Abstract

The literature regarding an association between thyroid disease and immune thrombocytopenic purpura (ITP) suggests that autoimmune thyroid disease is a frequent finding in patients with ITP. A strong association between other systemic autoimmune diseases and autoimmune thyroid diseases is also well documented. Therefore, the combination of autoimmune thyroid disease and ITP could reflect a more significant defect in the immune self-tolerance of these patients compared with those who have primary ITP alone. Such defects may characterize an ITP patient population as more refractory to standard ITP therapy. Screening patients for antithyroid antibodies would identify a patient population at greater risk of developing overt thyroid disease. These patients may be further screened with a thyroid-stimulating hormone assay to detect subclinical thyroid disease.

PMID:
19932432
DOI:
10.1016/j.hoc.2009.08.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center